DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading
3 articles
An experimental gene-editing drug cut LDL cholesterol by 62 percent after a single dose in a small trial, but proof of effect is not yet proof of broad safety.
Topical ABT-263 accelerated wound closure in aged mice and boosted gene signals tied to collagen production and tissue regeneration.
New blueprint aims to accelerate approvals for rare pediatric gene therapies.